Hepatitis C
 Treatments
Infergen (consensus interferon/interferon alfacon-1)
- Monotherapy -
INFERGEN is indicated for the treatment of chronic HCV infection in patients 18 years of age or older with compensated liver disease who have anti-HCV serum antibodies and/or the presence of HCV RNA.

 Infergen Product Information
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied



INFERGEN monotherapy significantly decreases HCV viral load2




INFERGEN® monotherapy is proven effective in hard-to-treat HCV patients, including nonresponders and relapsers1

1. Heathcote EJL, Keeffe EB, Lee SS, et al, and the Consensus Interferon Study Group. Re-treatment of chronic hepatitis C with consensus interferon. Hepatology. 1998;27:1136-1143.

2. Tong MJ, Reddy KR, Lee WM, et al. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Hepatology. 1997;26:747-754.



 

 

 

 

 

 

 

 

 

 

 

 

 

HIV AND AIDS | HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH | TESTS
| INTERNET CONFERENCE REPORTS | LINKS | ABOUT US | CONTACT US